IPO
-
-
-
-
-
-
-
Immuneering Added to the Nasdaq Biotechnology Index
-
-
-
-
-
-
-
Immuneering Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
122,324 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

